May 21, 2018 / 2:58 PM / in a month

BRIEF-Mabvax Therapeutics Updates On SEC Investigation, Accounting Discrepancies

May 21 (Reuters) - MabVax Therapeutics Holdings Inc :

* MABVAX THERAPEUTICS SAYS IN LIGHT OF SEC INVESTIGATION, UNABLE TO FILE FORM 10-Q FOR QUARTER ENDED MARCH 31, 2018 AT THIS TIME - SEC FILING

* MABVAX THERAPEUTICS- BELIEVE SEC INVESTIGATING POTENTIAL VIOLATIONS BY CO, OFFICERS & POTENTIAL VIOLATIONS BY MULTIPLE HOLDERS OF PREFERRED STOCK

* MABVAX THERAPEUTICS HOLDINGS INC - FURTHER BELIEVE SEC INVESTIGATION PERTAINS TO RELATIONSHIPS WITH MULTIPLE HOLDERS OF PREFERRED STOCK

* MABVAX THERAPEUTICS - APPOINTED SPECIAL COMMITTEE WITH INDEPENDENT MEMBERS OF BOARD TO SUPERVISE REVIEW OF MATTERS BELIEVED TO BE UNDER INVESTIGATION

* MABVAX THERAPEUTICS HOLDINGS INC - REVIEWING OUR INTERNAL AND DISCLOSURE CONTROLS

* MABVAX THERAPEUTICS HOLDINGS - ON MAY 20, AUDITORS WITHDREW THEIR AUDIT REPORTS INCLUDED IN ANNUAL REPORTS ON FORM 10-K FOR YRS 2014, 2015, 2016, 2017

* MABVAX - FINANCIAL STATEMENTS FOR 2014, 2015, 2016, 2017, REGISTRATION STATEMENTS FILED DURING THOSE YRS, TO DATE FOR 2018, SHOULD NOT BE RELIED UPON Source text : (bit.ly/2rZ7Gqg) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below